Changing trends in clinical characteristics and antibiotic susceptibility of Klebsiella pneumoniae bacteremia
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Klebsiella pneumoniae is second most common organism of gram-negative bacteremia in Korea and one of the most common cause of urinary tract infection, and intra-abdominal infection. Methods: We compared clinical and microbiological characteristics about K.pneumoniae bacteremia in a tertiary hospital between 10 years. Group A is who had K. pneumoniae bacteremia at least one time from January 2004 to December 2005. Group B is from January 2012 to December 2013. We also analyzed antibiotic resistance, clinical manifestation of the K. pneumoniae bacteremia divided into community-acquired infections, healthcare associated infections, and nosocomial infections. Results: The resistance for ampicillin, aztreonam, cefazolin, and cefotaxime significantly increased compared to 10 years ago. Extended spectrum β-lactamase positivity surged from 4.3% to 19.6%. Ten years ago, 1st, 2nd cephalosporin, and aminoglycoside were used more as empirical antibiotics. But these days, empirical antibiotics were broad spectrum such as 3rd and 4th cephalosporin. In treatment outcome, acute kidney injury decreased from 47.5% to 28.7%, and mortality decreased from 48.9% to 33.2%. In community-acquired infections, there was similar in antimicrobial resistance and mortality. In healthcare-associated and nosocomial infections, there was significantly increasing in antibiotic resistance, decreasing in mortality, and acute kidney injury. Conclusions: In community-acquired infections, broader antibiotics were more used than 10 years ago despite of similar antimicrobial resistance. When K. pneumoniae bacteremia is suspected, we recommend to use the narrow spectrum antibiotics as initial therapy if there are no healthcare-associated risk factors, because the antibiotic resistance is similar to 10 years ago in community-acquired infections.
Abstract
Background/Aims: Klebsiella pneumoniae is second most common organism of gram-negative bacteremia in Korea and one of the most common cause of urinary tract infection, and intra-abdominal infection. Methods: We compared clinical and microbiological characteristics about K.pneumoniae bacteremia in a tertiary hospital between 10 years. Group A is who had K. pneumoniae bacteremia at least one time from January 2004 to December 2005. Group B is from January 2012 to December 2013. We also analyzed antibiotic resistance, clinical manifestation of the K. pneumoniae bacteremia divided into community-acquired infections, healthcare associated infections, and nosocomial infections. Results: The resistance for ampicillin, aztreonam, cefazolin, and cefotaxime significantly increased compared to 10 years ago. Extended spectrum β-lactamase positivity surged from 4.3% to 19.6%. Ten years ago, 1st, 2nd cephalosporin, and aminoglycoside were used more as empirical antibiotics. But these days, empirical antibiotics were broad spectrum such as 3rd and 4th cephalosporin. In treatment outcome, acute kidney injury decreased from 47.5% to 28.7%, and mortality decreased from 48.9% to 33.2%. In community-acquired infections, there was similar in antimicrobial resistance and mortality. In healthcare-associated and nosocomial infections, there was significantly increasing in antibiotic resistance, decreasing in mortality, and acute kidney injury. Conclusions: In community-acquired infections, broader antibiotics were more used than 10 years ago despite of similar antimicrobial resistance. When K. pneumoniae bacteremia is suspected, we recommend to use the narrow spectrum antibiotics as initial therapy if there are no healthcare-associated risk factors, because the antibiotic resistance is similar to 10 years ago in community-acquired infections.
참고문헌 (14)
- 강철인, "Community-Acquired versus Nosocomial Klebsiella pneumoniae Bacteremia: Clinical Features, Treatment Outcomes, and Clinical Implication of Antimicrobial Resistance", Journal of Korean Medical Science, 21(5), pp.816~822 (2006), 대한의학회
- Sun HY, "Community-onset Escherichia coli and Klebsiella pneumoniae bacteremia: influence of health care exposure on antimicrobial susceptibility", Diagn Microbiol Infect Dis, 55, pp.135~141 (2006)[DOI]
- Kreger BE, "Gram-negative bacteremia. III. Reassessment of etiology, epidemiology and ecology in 612 patients", Am J Med, 68, pp.332~343 (1980)[DOI]
- Huh K, "Continuous increase of the antimicrobial resistance among gram-negative pathogens causing bacteremia: a nationwide surveillance study by the Korean Network for Study on Infectious Diseases (KONSID)", Diagn Microbiol Infect Dis, 76, pp.477~482 (2013)[DOI]
- Chung DR, "Emerging invasive liver abscess caused by K1 serotype Klebsiella pneumoniae in Korea", J Infect, 54, pp.578~583 (2007)[DOI]
- Jung Y, "Differences in characteristics between healthcare-associated and community-acquired infection in community-onset Klebsiella pneumoniae bloodstream infection in Korea", BMC Infect Dis, 12, pp.239~ (2012)[DOI]
- 위성헌, "최근 10년간 화농성 간농양 141예의 임상적 특성 및 원인균의 항균제 감수성 양상", Infection and Chemotherapy, 40(4), pp.199~206 (2008), 대한감염학회
- Garcia de la Torre M, "Klebsiella bacteremia: an analysis of 100 episodes", Rev Infect Dis, 7, pp.143~150 (1985)[DOI]
- Jang TN, "Nosocomial gram-negative bacteremia in critically ill patients: epidemiologic characteristics and prognostic factors in 147 episodes", J Formos Med Assoc, 98, pp.465~473 (1999)
- Sligl W, "Five years of nosocomial Gram-negative bacteremia in a general intensive care unit: epidemiology, antimicrobial susceptibility patterns, and outcomes", Int J Infect Dis, 10, pp.320~325 (2006)[DOI]
- 이정아, "지역사회 발생 폐렴막대균 균혈증에서 의료관련감염의 임상적, 미 생물학적 특성", Infection and Chemotherapy, 44(2), pp.56~61 (2012), 대한감염학회[DOI]
- Dellinger RP, "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012", Crit Care Med, 41, pp.580~637 (2013)[DOI]
- Lee JA, "Epidemiology and clinical features of community-onset bacteremia caused by extended-spectrum <TEX>${\beta}$<", TEX>-lactamase-producing Klebsiella pneumoniae, 2011, pp.17, 267~273
- Pirson M, "Financial consequences of hospital-acquired bacteraemia in three Belgian hospitals in 2003 and 2004", J Hosp Infect, 68, pp.9~16 (2008)[DOI]